• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

CATEGORIES

  • 10
  • 6
  • 6
  • 5
  • 2
  • 1
  • 1

PRICE

4
4
4
30

PUBLISHED

0
3
17
30

PRODUCT TYPE

27
3

Search "Lixte Biotechnology Holdings, Inc.-Therapeutic Competitors" returned 30 results.

Lixte Biotechnology Holdings, Inc. (LIXT) - Financial and Strategic SWOT Analysis Review

Lixte Biotechnology Holdings, Inc. (LIXT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has...

June 2015
FROM

Lixte Biotechnology Holdings, Inc. (LIXT) - Strategic Analysis Review

Lixte Biotechnology Holdings, Inc. (Lixte) is a research based cancer therapeutics and diagnostics company engaged in development of improved treatments of human cancers. The company is currently developing...

September 2010
FROM

Medulloblastoma - Pipeline Review, H1 2014

Medulloblastoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Medulloblastoma - Pipeline Review, H1 2014’, provides an overview of the Medulloblastoma’s therapeutic pipeline. This...

February 2014
FROM

Neurofibromatoses Type II - Pipeline Review, H1 2015

Neurofibromatoses Type II - Pipeline Review, H1 2015 Summary The‘Neurofibromatoses Type II - Pipeline Review, H1 2015’, provides an overview of the Neurofibromatoses Type II’s therapeutic pipeline. This...

May 2015
FROM

Neurofibromatoses Type II - Pipeline Review, H1 2014

Neurofibromatoses Type II - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Neurofibromatoses Type II - Pipeline Review, H1 2014’, provides an overview of the Neurofibromatoses Type II’s...

February 2014
FROM

Brain Ischemia - Pipeline Review, H1 2014

Brain Ischemia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Brain Ischemia - Pipeline Review, H1 2014’, provides an overview of the Brain Ischemia’s therapeutic pipeline. This report...

May 2014
FROM

Gaucher's Disease - Pipeline Review, H1 2015

Gaucher's Disease - Pipeline Review, H1 2015 Summary This, ‘Gaucher's Disease - Pipeline Review, H1 2015’, provides an overview of the Gaucher's Disease’s therapeutic pipeline. This report provides...

January 2015
FROM

Brain Ischemia - Pipeline Review, H2 2014

Brain Ischemia - Pipeline Review, H2 2014 Summary This, ‘Brain Ischemia - Pipeline Review, H2 2014’, provides an overview of the Brain Ischemia’s therapeutic pipeline. This report provides comprehensive...

November 2014
FROM

Brain Ischemia - Pipeline Review, H1 2015

Brain Ischemia - Pipeline Review, H1 2015 Summary This, ‘Brain Ischemia - Pipeline Review, H1 2015’, provides an overview of the Brain Ischemia’s therapeutic pipeline. This report provides comprehensive...

April 2015
FROM

Gaucher's Disease - Pipeline Review, H2 2014

Gaucher's Disease - Pipeline Review, H2 2014 Summary This, ‘Gaucher's Disease - Pipeline Review, H2 2014’, provides an overview of the Gaucher's Disease’s therapeutic pipeline. This report provides...

November 2014
FROM

Myocardial Ischemia - Pipeline Review, H1 2015

Myocardial Ischemia - Pipeline Review, H1 2015 Summary This, ‘Myocardial Ischemia - Pipeline Review, H1 2015’, provides an overview of the Myocardial Ischemia’s therapeutic pipeline. This report...

February 2015
FROM

Myocardial Ischemia - Pipeline Review, H2 2014

Myocardial Ischemia - Pipeline Review, H2 2014 Summary This, ‘Myocardial Ischemia - Pipeline Review, H2 2014’, provides an overview of the Myocardial Ischemia’s therapeutic pipeline. This report...

October 2014
FROM

Neurofibromatoses Type II - Pipeline Review, H2 2014

Neurofibromatoses Type II - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Neurofibromatoses Type II - Pipeline Review, H2 2014’, provides an overview of the Neurofibromatoses Type II’s...

July 2014
FROM

Competitor Analysis: Enzyme Replacement Therapies

The Competitive Intelligence Report Enzyme Replacement & Enhancement Therapies (ERT) as of January 2013 provides a competitor analysis in the development pipeline of novel enzyme replacement therapies...

January 2013
FROM

Ischemia - Pipeline Review, H2 2014

Ischemia - Pipeline Review, H2 2014 Summary This, ‘Ischemia - Pipeline Review, H2 2014’, provides an overview of the Ischemia’s therapeutic pipeline. This report provides comprehensive information...

December 2014
FROM

Septic Shock - Pipeline Review, H1 2015

Septic Shock - Pipeline Review, H1 2015 Summary This, ‘Septic Shock - Pipeline Review, H1 2015’, provides an overview of the Septic Shock’s therapeutic pipeline. This report provides comprehensive...

April 2015
FROM

Septic Shock - Pipeline Review, H2 2014

Septic Shock - Pipeline Review, H2 2014 Summary This, ‘Septic Shock - Pipeline Review, H2 2014’, provides an overview of the Septic Shock’s therapeutic pipeline. This report provides comprehensive...

December 2014
FROM

Traumatic Brain Injury - Pipeline Review, H2 2014

Traumatic Brain Injury - Pipeline Review, H2 2014 Summary This, ‘Traumatic Brain Injury - Pipeline Review, H2 2014’, provides an overview of the Traumatic Brain Injury’s therapeutic pipeline. This...

October 2014
FROM

Traumatic Brain Injury - Pipeline Review, H1 2014

Traumatic Brain Injury - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Traumatic Brain Injury - Pipeline Review, H1 2014’, provides an overview of the Traumatic Brain Injury’s therapeutic...

April 2014
FROM

Traumatic Brain Injury - Pipeline Review, H1 2015

Traumatic Brain Injury - Pipeline Review, H1 2015 Summary: This, ‘Traumatic Brain Injury - Pipeline Review, H1 2015’, provides an overview of the Traumatic Brain Injury’s therapeutic pipeline. This...

March 2015
FROM
Loading Indicator

Our Clients

Innocent Drinks Ltd. Groupe Danone Cisco Systems, Inc. The World Bank Group Swarovski AG Owens Corning Corporation Swiss Reinsurance Company Ltd.